Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
Condition: End Stage Renal Disease Interventions: Drug: 0.7% Xylitol, 0.5% Glucose, and 0.02% L-carnitine - or - 1.5% Xylitol, 0.5% Glucose, and 0.02% L-carnitine - or - 2.0% Xylitol, 1.5% Glucose, and 0.02% L-carnitine; Drug: 1.36% or 2.27% or 3.86% Glucose Sponsor: Iperboreal Pharma Srl Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials